Volume 41 Supplement 2

71st Congress of the Italian Society of Pediatrics

Open Access

“Gestalt diagnosis” for children with suspected genetic syndromes

Italian Journal of Pediatrics201541(Suppl 2):A16

https://doi.org/10.1186/1824-7288-41-S2-A16

Published: 30 September 2015

Gestalt identification is the process by which healthcare practitioners actively organize clinical perceptions into specific diagnostic ideas. This implies that clinicians, in particular geneticists, have the ability to quickly generate diagnostic hypotheses in absence of complete information, simply on the basis of combination of specific facial dysmorphisms or particular elements of the clinical history. This is particularly frequent in clinical genetics because the “facial dysmorphisms” of the patient represent often the most specific clinical criteria of the syndrome itself. Down [1], Cornelia de Lange [2], Wolf-Hirshhorn [3], Noonan [4], Rubistein-Taybi [5] Kabuki [6], Treacher Collins [7] and Williams syndrome [8] are examples well known to pediatricians but this is true for the great majority of genetic syndromes. In these situations facial dysmrphisms can have variable expression between different patients (also in the same family) or can become more or less evident over time. Moreover the “gestalt process” can also be applied in case of specific auxologic and/or neurologic evolution. In patients with Prader-Willi syndrome (PWS) in the first months of life hypotonia is evident and tends to improve between 8 and 11 months of age; poor growth and feeding problems are frequent too. Later on hypotonia improves and feeding difficulties are replaced by hyperphagia and obesity. This typical evolution can permit to suspect in every phase PWS diagnosis and to perform methylation test for 15q11.2 region [9]. Some neuro pediatricians suggest that Angelman syndrome's EEG pattern is typical enough to be recognized by sensitized professionals [10]. A specific behavioral phenotype, including significant sleep disturbance, stereotypies and oppositional behavior, is pretty characteristic of Smith-Magenis syndrome [11]. Again, PTEN gene testing may be considered for patients with extreme macrocephaly associated with intellectual disability/autistic behaviour [12]. Within overgrowth syndrome, Beckwith-Wiedemann syndrome (BWS) can be easily recognized thanks to the association between hemi-hypertrophy, macroglossia, abdominal wall defects and frontal nevus flammeus [13]. Finally within patients with short stature the evidence of disproportion between crown-rump and overall lengths, or between limbs and trunk univocally direct the diagnosis toward the skeletal dysplasias [14].

In conclusion the knowledge of facial features and/or natural history (auxological, neurological behavioural etc) of the most common genetic syndromes can help pediatricians in hypothesizing them through a “gestalt process” in order to quickly confirm the clinical diagnosis with the specific genetic tests.

Declarations

Acknowledgements

We thank the Mariani Foundation, Milan Italy, for their support of the Pediatric Genetic Clinic within the Pediatric Department of the MBBM Foundation San Gerardo Hospital Monza.

Authors’ Affiliations

(1)
Pediatric Genetic Unit, Pediatric Department, Milano Bicocca University
(2)
Pediatric Department, Insubria University

References

  1. Allanson JE, O'Hara Farkas LG, Nair RC: Anthropometric craniofacial pattern profiles in Down syndrome. Am J Med Genet. 1993, 47: 748-752. 10.1002/ajmg.1320470530.PubMedView ArticleGoogle Scholar
  2. Mannini L, Cucco F, Quarantotti V, Krantz ID, Musio A: Mutation spectrum and genotype-phenotype correlation in Cornelia de Lange syndrome. Hum Mutat. 2013, 34: 1589-1596. 10.1002/humu.22430.PubMedView ArticleGoogle Scholar
  3. Sukarova-Angelovska E, Kocova M, Sabolich V, Palcevska S, Angelkova N: Phenotypic variations in Wolf-Hirschhorn syndrome. Balkan J Med Genet. 2014, 11: 23-30.Google Scholar
  4. Allanson JE, Hall JG, Hughes HE, Preus M, Witt RD: Noonan syndrome: the changing phenotype. Am J Med Genet. 1985, 21: 507-514. 10.1002/ajmg.1320210313.PubMedView ArticleGoogle Scholar
  5. Milani D, Manzoni FM, Pezzani L, Ajmone P, Gervasini C, Menni F, et al: Rubinstein-Taybi syndrome: clinical features, genetic basis, diagnosis, and management. Ital J Pediatr. 2015, 20: 41-44.Google Scholar
  6. Bokinni Y: Kabuki syndrome revisited. J Hum Genet. 2012, 57: 223-227. 10.1038/jhg.2012.28.PubMedView ArticleGoogle Scholar
  7. Dixon MJ: Treacher Collins syndrome. Hum Mol Genet. 1996, 5: 1391-1396.PubMedGoogle Scholar
  8. Morris CA, Demsey SA, Leonard CO, Dilts C, Blackburn BL: Natural history of Williams syndrome: physical characteristics. J Pediatr. 1988, 113: 318-326. 10.1016/S0022-3476(88)80272-5.PubMedView ArticleGoogle Scholar
  9. Fridman C, Kok F, Koiffmann CP: Hypotonic infants and the Prader-Willi Syndrome. J Pediatr (Rio J). 2000, 76: 246-250.View ArticleGoogle Scholar
  10. Williams CA: Neurological aspects of the Angelman syndrome. Brain Dev. 2005, 27: 88-94. 10.1016/j.braindev.2003.09.014.PubMedView ArticleGoogle Scholar
  11. Dykens EM, Smith AC: Distinctiveness and correlates of maladaptive behaviour in children and adolescents with Smith-Magenis syndrome. J Intellect Disabil Res. 1998, 42: 481-489. 10.1046/j.1365-2788.1998.4260481.x.PubMedView ArticleGoogle Scholar
  12. McBride KL, Varga EA, Pastore MT, Prior TW, Manickam K, Atkin JF, et al: Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. Autism Res. 2010, 15: 137-141.View ArticleGoogle Scholar
  13. Pappas JG: The clinical course of an overgrowth syndrome, from diagnosis in infancy through adulthood: the case of Beckwith-Wiedemann Syndrome. Curr Probl Pediatr Adolesc Health Care. 2015, 45: 112-117. 10.1016/j.cppeds.2015.03.001.PubMedView ArticleGoogle Scholar
  14. Brook CG, de Vries BB: Skeletal dysplasias. Arch Dis Child. 1998, 79: 285-289. 10.1136/adc.79.3.285.PubMedPubMed CentralView ArticleGoogle Scholar

Copyright

© Cianci and Selicorni 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement